Fertility drugmaker EMD Serono, the U.S. arm of Merck KGaA, will offer its in vitro fertilization (IVF) treatments at a sharp discount on the government's DTC platform TrumpRx.
As a newly christened manufacturing facility comes online in one part of Ireland, Merck KGaA plans to turn out the lights at ...
President Donald Trump on Friday announced a deal with pharmaceutical company Merck and its U.S. subsidiary, EMD Serono, to ...
Government agreement with IVF drug manufacturer drops price in exchange for tariff reductions, expedited FDA approval ...
EMD Serono has partnered the Trump administration to expand access to the company’s in vitro fertilisation (IVF) therapies.
President Donald Trump announced a new agreement aimed at significantly lowering the cost of fertility treatments for ...
Merck KGaA has become the third pharma company to reach an agreement with the Trump administration to cut the cost of some of ...
EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, and President Donald J.
U.S. President Donald Trump and Germany's Merck KGaA on Thursday said they had struck a deal that would cut the cost of some ...